This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-01.
Status change: Not Yet Recruiting → Recruiting2026-03-24